SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001358403-19-000121
Filing Date
2019-11-06
Accepted
2019-11-06 16:32:30
Documents
3
Period of Report
2019-11-06
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a2019q38-kpressrelease.htm 8-K 34815
2 EXHIBIT 99.1 exh991-2019q3earningsrelea.htm EX-99.1 152171
3 bellicumlogoa28.jpg GRAPHIC 27677
  Complete submission text file 0001358403-19-000121.txt   226399
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 191196801
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences